Literature DB >> 25752835

Hypertension: Renal denervation-promising data from the DENERHTN trial.

Wen-Yi Yang1, Jan A Staessen1.   

Abstract

In patients with resistant hypertension, renal denervation plus standardized stepped-care antihypertensive treatment (SSAHT) resulted in significant blood-pressure lowering compared with SSAHT alone. These new data from the DENERHTN trial may indicate that despite the failure of SYMPLICITY HTN-3, there is light at the end of the tunnel for renal denervation.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25752835     DOI： 10.1038/nrneph.2015.28

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  10 in total

1.  Nocebo effects, patient-clinician communication, and therapeutic outcomes.

Authors:  Luana Colloca; Damien Finniss
Journal:  JAMA       Date:  2012-02-08       Impact factor: 56.272

2.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Authors:  Murray D Esler; Henry Krum; Paul A Sobotka; Markus P Schlaich; Roland E Schmieder; Michael Böhm
Journal:  Lancet       Date:  2010-11-17       Impact factor: 79.321

3.  Blood pressure response to renal nerve stimulation in patients undergoing renal denervation: a feasibility study.

Authors:  P Gal; M R de Jong; J J J Smit; A Adiyaman; J A Staessen; A Elvan
Journal:  J Hum Hypertens       Date:  2014-10-23       Impact factor: 3.012

4.  Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study.

Authors:  Ján Rosa; Petr Widimský; Petr Toušek; Ondřej Petrák; Karol Čurila; Petr Waldauf; František Bednář; Tomáš Zelinka; Robert Holaj; Branislav Štrauch; Zuzana Šomlóová; Miloš Táborský; Jan Václavík; Eva Kociánová; Marian Branny; Igor Nykl; Otakar Jiravský; Jiří Widimský
Journal:  Hypertension       Date:  2014-11-24       Impact factor: 10.190

5.  Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial.

Authors:  Michel Azizi; Marc Sapoval; Philippe Gosse; Matthieu Monge; Guillaume Bobrie; Pascal Delsart; Marco Midulla; Claire Mounier-Véhier; Pierre-Yves Courand; Pierre Lantelme; Thierry Denolle; Caroline Dourmap-Collas; Hervé Trillaud; Helena Pereira; Pierre-François Plouin; Gilles Chatellier
Journal:  Lancet       Date:  2015-01-26       Impact factor: 79.321

6.  Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.

Authors: 
Journal:  Hypertension       Date:  2011-03-14       Impact factor: 10.190

7.  Increased peripheral release of noradrenaline and uptake of adrenaline in essential hypertension?

Authors:  S E Kjeldsen; B Flaaten; I Eide; A Helgeland; P Leren
Journal:  Clin Sci (Lond)       Date:  1981-12       Impact factor: 6.124

8.  Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.

Authors:  Fadl Elmula M Fadl Elmula; Pavel Hoffmann; Anne C Larstorp; Eigil Fossum; Magne Brekke; Sverre E Kjeldsen; Eyvind Gjønnæss; Ulla Hjørnholm; Vibeke N Kjaer; Morten Rostrup; Ingrid Os; Aud Stenehjem; Aud Høieggen
Journal:  Hypertension       Date:  2014-03-03       Impact factor: 10.190

9.  Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial.

Authors:  Jan A Staessen; Elly Den Hond; Hilde Celis; Robert Fagard; Louis Keary; Guy Vandenhoven; Eoin T O'Brien
Journal:  JAMA       Date:  2004-02-25       Impact factor: 56.272

10.  A controlled trial of renal denervation for resistant hypertension.

Authors:  Deepak L Bhatt; David E Kandzari; William W O'Neill; Ralph D'Agostino; John M Flack; Barry T Katzen; Martin B Leon; Minglei Liu; Laura Mauri; Manuela Negoita; Sidney A Cohen; Suzanne Oparil; Krishna Rocha-Singh; Raymond R Townsend; George L Bakris
Journal:  N Engl J Med       Date:  2014-03-29       Impact factor: 91.245
  10 in total
  1 in total

Review 1.  Catheter-Based Renal Nerve Ablation as a Novel Hypertension Therapy: Lost, and Then Found, in Translation.

Authors:  John W Osborn; Christopher T Banek
Journal:  Hypertension       Date:  2018-01-02       Impact factor: 10.190
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.